# Plausible Obesity-Related Chronometabolic and Nutrigenetic Nexus Concerning Dinner Glycemic Index and the FAAH C385A Variant

**Authors:** Barbara Vizmanos, Alejandra Betancourt-Núñez, Erika Sierra-Ruelas, Juan José López Gómez, Daniel Rico, J. Alfredo Martínez, Daniel A. De Luis

PMC · DOI: 10.3390/biom16020274 · Biomolecules · 2026-02-09

## TL;DR

This study explores how dinner's glycemic index and a genetic variant in FAAH may influence blood sugar and insulin levels in obese adults.

## Contribution

The study introduces a plausible chrono-nutrigenetic interaction between dinner GI, FAAH C385A variant, and metabolic regulation in obesity.

## Key findings

- Higher dinner glycemic index was inversely associated with fasting glucose levels in obese adults.
- The FAAH C385A variant independently predicted lower insulin and HOMA-IR levels.
- No significant interaction was found between dinner GI and FAAH genotype on glycemic outcomes.

## Abstract

The interaction between chrono-nutrition (dinner intake), glycemic index (GI), and the C358A variant of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH), along with its impact on morning fasting insulin and glycemia, has not been previously explored. This study provides new insights into chronometabolic and nutrigenetic interactions. This study aims to analyze the association between the dinner GI and the C385A variant in the FAAH gene with respect to fasting glucose, insulin levels, and HOMA-IR in adults with obesity. It was hypothesized that the dinner GI, probably influenced by the FAAH variant, could be associated with glycemic homeostasis in adults with obesity. This is a secondary analysis of a cross-sectional study focused on 189 adults with obesity (129 women; mean age, 41 ± 12 years; mean BMI, 38.0 ± 5.2 kg/m2). Dietary intake was assessed through two 24 h food records, enabling the calculation of GI and macronutrient composition at each meal, especially dinner. Fasting-parameter setting and genotyping were done during the study. The lineal regression analyses were adjusted by age, sex, BMI, energy intake and dinner protein. Participants with lower fasting glucose levels had higher total GI and dinner GI values than those with higher fasting glucose levels, whereas no differences in dinner GI were observed across groups stratified by insulin or HOMA-IR levels. In fully adjusted regression models, dinner GI values remained inversely associated with fasting glucose levels (β = −0.172, 95%CI −0.298 to −0.045; p = 0.008). The FAAH C385A variant independently predicted lower insulin (β = −2.674, 95%CI −5.185 to −0.164; p = 0.037) and lower HOMA-IR (β = −0.731, 95%CI −1.364 to −0.099; p = 0.024) levels. No statistically significant interaction between dinner GI and the FAAH genotype was detected with respect to glycemia, insulin, and HOMA-IR. Overall, these findings indicate that the dinner GI influences fasting glucose levels in adults with obesity; the FAAH variant predicted lower insulin and HOMA-IR levels, supporting a plausible chrono-nutrigenetic interaction between carbohydrate quality, mealtime intake, and FAAH variation in metabolic regulation, which must be further studied.

## Linked entities

- **Genes:** FAAH (fatty acid amide hydrolase) [NCBI Gene 2166]
- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** FAAH (fatty acid amide hydrolase) [NCBI Gene 2166] {aka FAAH-1, FAAH1, PSAB}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, Faah (fatty acid amide hydrolase) [NCBI Gene 14073], CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, GNAI1 (G protein subunit alpha i1) [NCBI Gene 2770] {aka Gi, HG1B, NEDHISB}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}
- **Diseases:** CVD (MESH:D002318), bodyweight loss (MESH:D015431), Insulin Resistance Atherosclerosis (MESH:D007333), hypertension (MESH:D006973), impaired glucose tolerance (MESH:D018149), T2DM (MESH:D003924), adiposity (MESH:D018205), Reduced (MESH:D001523), diabetic (MESH:D003920), neuroinflammatory (MESH:D000090862), inflammation (MESH:D007249), injury to (MESH:D014947), metabolic disturbances (MESH:D024821), hyperglycemia (MESH:D006943), dyslipidemia (MESH:D050171), metabolic disorders (MESH:D008659), metabolic dysregulation (MESH:D021081), Obesity (MESH:D009765), overweight (MESH:D050177), stroke (MESH:D020521)
- **Chemicals:** carbohydrate (MESH:D002241), AEA (-), melatonin (MESH:D008550), Glucose (MESH:D005947), polyphenols (MESH:D059808), thiazolidinediones (MESH:D045162), lipid (MESH:D008055), LP (MESH:D008070), endocannabinoid (MESH:D063388), anandamide (MESH:C078814), blood glucose (MESH:D001786), CHO (MESH:C034482), metformin (MESH:D008687), sulfonylureas (MESH:D013453)
- **Species:** Homo sapiens (human, species) [taxon 9606], gut metagenome (species) [taxon 749906], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** Pro/Thr, Thr/Thr, Rs1800629, C358A, Thr129Thr, Rs3749474, Pro129Pro, C358A, 385 A/A, C385A, Pro/Pro

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937749/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12937749/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937749/full.md

---
Source: https://tomesphere.com/paper/PMC12937749